AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -66.7% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -20.0% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | +66.7% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | +50.0% | 500 | +66.7% | 0.00% | – |
| Q2 2020 | $2,000 | -98.3% | 300 | -97.3% | 0.00% | – |
| Q2 2017 | $121,000 | +2925.0% | 10,956 | +2484.0% | 0.00% | – |
| Q1 2017 | $4,000 | – | 424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
| JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
| BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
| Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
| Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
| WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
| Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |